| Line item | 2025-12-31 FY | 2024-12-31 FY | 2024-09-30 FY | 2023-09-30 FY | 2022-09-30 FY | 2021-09-30 FY |
|---|---|---|---|---|---|---|
| Revenue | $11.80K | – | – | – | – | – |
| Cost of Revenue | $12.67K | – | – | – | – | – |
| Gross Profit | -$870.00 | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | – | – | – | – | – | – |
| SG&A | $320.22K | $98.43K | $230.55K | $165.36K | $108.20K | $572.68K |
| Operating Income | -$320.22K | -$98.43K | -$230.55K | -$165.36K | -$108.20K | -$572.68K |
| Interest Expense | $9.98K | – | – | – | – | – |
| Tax Expense | – | – | – | – | – | – |
| Net Income | -$331.07K | -$98.43K | -$216.15K | $23.78K | -$108.20K | -$454.07K |
| EPS (basic) | -0.0500 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | -0.0100 |
| EPS (diluted) | -0.0500 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | -0.0100 |
| Shares (diluted) | $68.91M | $68.91M | $88.71M | $67.14M | $62.05M | $61.91M |